KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBIT: 2009-2024

Historic EBIT for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to -$1.0 billion.

  • Exact Sciences' EBIT rose 35.17% to -$25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 316.35%. This contributed to the annual value of -$1.0 billion for FY2024, which is 387.74% down from last year.
  • According to the latest figures from FY2024, Exact Sciences' EBIT is -$1.0 billion, which was down 387.74% from -$215.0 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' EBIT ranged from a high of -$215.0 million in FY2023 and a low of -$1.0 billion during FY2024.
  • Moreover, its 3-year median value for EBIT was -$593.5 million (2022), whereas its average is -$619.1 million.
  • In the last 5 years, Exact Sciences' EBIT soared by 63.77% in 2023 and then plummeted by 387.74% in 2024.
  • Exact Sciences' EBIT (Yearly) stood at -$767.7 million in 2020, then fell by 11.46% to -$855.7 million in 2021, then surged by 30.64% to -$593.5 million in 2022, then skyrocketed by 63.77% to -$215.0 million in 2023, then slumped by 387.74% to -$1.0 billion in 2024.